Respiratory Monitoring Devices Industry Trends
Factors at the forefront of driving the demand in the global respiratory monitoring devices market are the rising number of cigarette smokers and a worsening air quality on account of rampant pollution. Further, a burgeoning geriatric population highly susceptible to lung diseases has also pushed up the demand in the market. Countering its growth, however, are the steep prices of newer, sophisticated respiratory monitoring devices, particularly advanced spirometry devices. They are much more expensive than peak flow meters or even pulse oximeters. This has somewhat dampened the demand for improved products leveraging better technologies. Further, dearth of skilled personnel to install advanced respiratory monitoring devices is also creating a gap between demand and supply in the market.
View Report @ http://www.transparencymarketresearch.com/respiratory-monitoring-devices.html
Expanding at a healthy CAGR of 8.2% from 2015 to 2023, the global market for respiratory monitoring devices is predicted to achieve a value of US$2.79 bn in 2023.
Widespread Prevalence of Asthma and COPD makes North America Market Leader
The Centers for Disease Control and Prevention (CDC) pegged chronic lower respiratory disease (COPD) as the third main cause of death in the U.S. in 2014. As per its findings, about 15.7 million people, which is about 6.4% of the nation’s population, were afflicted with COPD in 2014. Numbers were equally alarming for asthma cases. In fact, North America has the maximum cases of COPD and asthma and this has been the single-most important factor driving robust uptake of respiratory monitoring devices in the continent, thereby catapulting it to the leading position in the global market. The market in North America is slated to attain a value of US$266.0 mn by 2023.
Get accurate market forecast and analysis on the Respiratory Monitoring Devices Market. Request a sample to stay abreast on the key trends impacting this market.
Europe is another dominant market on account of the widespread prevalence of cystic fibrosis. Asia Pacific is proving to be a promising market too due to solid pace of development of healthcare and medical devices industries in the region. Other factors positively impacting its market are the strong economic growth in the densely populated countries of China and India, rising instances of respiratory illnesses, increasing government aid in healthcare development, and soaring popularity of medical tourism. The market in Asia Pacific is expected to register a healthy CAGR of 8.5% from 2015 to 2023.
Hospitals Generate Maximum Revenue due to Better Respiratory Monitoring Devices
Depending upon end users, the global market for respiratory monitoring devices can be segmented into laboratories, hospitals, and home use. Among them, hospitals lead the market with maximum share. Going forward too, it is predicted to retain its dominant share by exhibiting a stellar CAGR of 8.3% from 2015 to 2023. In terms of revenue, hospitals are slated to attain a value of US$1.89 bn by 2023. This is because of the large number of patients opting for treatment in hospitals for different respiratory problems. The trend is most noticeable in developed countries where hospitals have advanced respiratory monitoring devices for diagnosing modern strains of respiratory diseases.
In terms of product, the market can be classified into peak flow meter, spirometer, capnograps, and pulse oximeters. The global market for respiratory monitoring devices is dominated by a few players who hold a sizeable chunk of the market share. A host of other smaller players compete with each for the remaining share. Some of the prominent names in the market are CareFusion Corporation, Smiths Medical, and ResMed, Inc. On account of the presence of both large and small players, the global respiratory monitoring devices market is highly competitive. This market is dynamic too as it is characterized by rapid technological development.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Monitoring Devices Industry Trends here
News-ID: 675254 • Views: 365
More Releases from Transparency Market Research
Impact of Outbreak of COVID-19 on Automotive Retreaded Tires Market
Global Automotive Retreaded Tires Market: Snapshot Retreading is a re-fabricating process through which worn out and old tire tracks are superseded by the new ones. Retreading is connected to keeping of old tires after assessment. Retreading of tires comes at almost 40% less than the original new tires. The cost viability offered by retread tires is one of the essential factor fueling market development, which is additionally enhanced by the
Impact of Outbreak of COVID-19 on Feed Yeast Market
Yeast is called a single-celled fungus. The yeast that is applied in food and feed is known as Saccharomyces Cerevisiae. Feed yeast find major application in ruminants since they are considered to be the most developed market for live yeast usage. Further, few strains of Saccharomyces Cerevisiae can help prevent the reduction in the rumen pH which is linked with feeding a diet based on cereals and this seems to
Hair Shampoo Market Facts, Figures And Analytical Insights 2026
Hair shampoo is a type of cleanser that is used on the hair for a variety of purposes such as cleaning, hair fall, and smoothening. Large number of brands are available in the market. Organic shampoos are increasingly being adopted. Demand for organic shampoos is rising due to the increase in awareness about using natural and plant-based products. Dry and solid shampoos are another niche; however, these have high growth
Electrical Toothbrush Market Share, Growth, Forecast,Industry Outlook 2025
The electrical toothbrush is a kind of toothbrush that makes rapid, automatic bristle motions to clean the teeth. Brushing teeth manually may cause the damage of enamel and gum. Electric toothbrush comes with a pressure sensor, which prevents users from brushing too aggressively that may affect the person. It is easier to use than manual toothbrush and has multiple brushing mode such as daily brushing, gum care, deep clean, tongue
More Releases for COPD
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the